unmet clinical needs for platinum-resistant ovarian cancer patients
Published 5 years ago • 169 plays • Length 1:41Download video MP4
Download video MP3
Similar videos
-
1:05
areas of unmet need for patients with ovarian cancer
-
1:09
dr. arend on unmet needs in platinum-resistant ovarian cancer
-
1:19
relacorilant nab-paclitaxel in recurrent, platinum-resistant ovarian cancer
-
0:47
remaining areas of unmet need for patients with locally advanced pancreatic cancer
-
0:41
unmet clinical needs for muscle-invasive bladder cancer
-
0:35
phase i dose expansion results of cyt-0851 plus capecitabine in platinum-resistant ovarian cancer
-
2:39
recognizing the need to improve ovarian cancer cure rates
-
0:56
what makes cancer treatment worth it for patients
-
2:05
unmet needs for palliative care in oncology
-
1:22
overcoming resistance to parp inhibition in ovarian cancer
-
3:12
the unmet needs in palliative care for breast cancer
-
2:50
aurelia: phase 3 trial of bevacizumab combined with chemotherapy for ovarian cancer
-
3:15
unmet needs in ovarian cancer
-
6:57
case 4: i-o therapy for platinum-resistant recurrent disease
-
1:50
niraparib as maintenance for platinum-sensitive ovarian cancer - results from engot-ov16/nova trial
-
1:40
neo trial: neoadjuvant olaparib in platinum-sensitive relapsed high-grade serous ovarian cancer
-
5:40
diagnosis of metastatic platinum-resistant ovarian cancer
-
2:30
bladder cancer: unmet need for novel therapies
-
59:55
tackling platinum resistant ovarian cancer